Member Info for Kiwi_

Overhang almost depleted!

As in Peel Hunt the Market Maker?

Sham, which institutional investors are you referring to?

I'm still adding as and where I can.

PMSL, not gone anywhere Princess sorry

I've been there many a time, my advice: Cut the losers and add or invest in new winners

BREAKING NEWS: RNS INBOUND AHOY!

If it's not Monday it certainly ain't far away now!

https://twitter.com/Watermelon_AIM/status/1244581723834368000/photo/1

LID Lidco remains well below the Covid19 radar. Just try searching for #LID or #LIDCO on Twitter and you will only find news articles from the company and no posts from investors. Lidco recently were requested to increase supply to Wuhan as can be seen in this link:

BRIEF-Lidco Sells More Monitors To Hospitals In Wuhan Due To Covid-19

1 Min Read

March 9 (Reuters) - Lidco Group PLC:

* LIDCO GROUP PLC - INCREASED CHINA SALES DEMAND DUE TO COVID-19

* LIDCO- BEIJING GLORYWAY MEDICAL RECENTLY SOLD SMALL NUMBER OF MONITORS IN WUHAN, CHINA AS A DIRECT RESPONSE TO COVID-19 VIRUS OUTBREAK

* LIDCO - IN TALKS WITH HEALTHCARE INSTITUTIONS IN NUMBER OF AFFECTED AREAS, PREPARED TO BE FLEXIBLE TO MEET ANY SHORTTERM INCREASED MONITORING NEEDS Source text for Eikon:

https://www.reuters.com/article/brief-lidco-sells-more-monitors-to-hospi/brief-lidco-sells-more-monitors-to-hospitals-in-wuhan-due-to-covid-19-idUSFWN2B20B6

Whilst this just appeared on their website:
A message to the healthcare providers we supportaround the world,We know that with the complex and ever-changing COVID-19 outbreak, you are concerned about protecting the health of your patients and your employees. We too recognise our responsibility as a medical device manufacturer to support the medical community. We are prioritising our activities so that you can feel confident in our ability to support you during this situation. Our operations teams have been working additional hours including the weekends to maintain continuity of supply and service. Our customer service teams are able, if it becomes necessary, to work remotely to support your requests. We are also working closely with government agencies and couriers to monitor the situation and make contingency plans to ensure we can deliver products. We have taken steps to ensure that our employees understand and follow preventative measures recommended by local health authorities and the World Health Organization (WHO). We have implemented employee travel restrictions and postponed events. However, our representatives and clinical teams are here for you and want to help you in whatever capacity you need.Finally, thank you for your efforts at this challenging time -You are all heroes to us!The LiDCO Team

http://www.lidco.com/wp-content/uploads/2020/03/COVID-19.pdf

Just look at the major shareholders, Credit Suisse is on the list. Plenty of cash in the Bank with a 20% increase last year alone and clearly there is high demand for their product

Shareholders
Name Equities %
Alto Invest SA 24,387,442 9.99%
Ingalls & Snyder LLC 17,125,579 7.01%
Joe Leitch 16,806,183 6.88%
Herald Investment Management Ltd. 16,666,667 6.83%
Paul Brewer 15,884,747 6.51%
Hargreaves Lansdown Stockbrokers Ltd. 14,108,000 5.78%
James Lawrence Ede-Golightly 12,300,000 5.04%
Credit Suisse Asset Management Ltd. 11,829,000 4.84%
Robert Greenshields 8,899,550 3.64%
Terence K. O'Brien 8,251,563 3.38%

There is every possibilty of that mate, also with Lid Lidco to

Beyond that initial resistance and first target of 13.25p I have 17.5p followed by 27p, anyway not long to wait for the next RNS update here

News will land here, we may even get a new/increase TR1/Holdings before the trading update

REAT and LID Lidco will be the two next baggers, both are due news with REAT due a trading update whilst LID Lidco is due an RNS update on the 19th April if not beforehand

LID Lidco remains well below the Covid19 radar. Just try searching for #LID or #LIDCO and you will only find news articles from the company. Lidco recently were requested to increase supply to Wuhan as can be seen in this link:

BRIEF-Lidco Sells More Monitors To Hospitals In Wuhan Due To Covid-19

1 Min Read

March 9 (Reuters) - Lidco Group PLC:

* LIDCO GROUP PLC - INCREASED CHINA SALES DEMAND DUE TO COVID-19

* LIDCO- BEIJING GLORYWAY MEDICAL RECENTLY SOLD SMALL NUMBER OF MONITORS IN WUHAN, CHINA AS A DIRECT RESPONSE TO COVID-19 VIRUS OUTBREAK

* LIDCO - IN TALKS WITH HEALTHCARE INSTITUTIONS IN NUMBER OF AFFECTED AREAS, PREPARED TO BE FLEXIBLE TO MEET ANY SHORTTERM INCREASED MONITORING NEEDS Source text for Eikon:

https://www.reuters.com/article/brief-lidco-sells-more-monitors-to-hospi/brief-lidco-sells-more-monitors-to-hospitals-in-wuhan-due-to-covid-19-idUSFWN2B20B6

A message to the healthcare providers we supportaround the world,We know that with the complex and ever-changing COVID-19 outbreak, you are concerned about protecting the health of your patients and your employees. We too recognise our responsibility as a medical device manufacturer to support the medical community. We are prioritising our activities so that you can feel confident in our ability to support you during this situation. Our operations teams have been working additional hours including the weekends to maintain continuity of supply and service. Our customer service teams are able, if it becomes necessary, to work remotely to support your requests. We are also working closely with government agencies and couriers to monitor the situation and make contingency plans to ensure we can deliver products. We have taken steps to ensure that our employees understand and follow preventative measures recommended by local health authorities and the World Health Organization (WHO). We have implemented employee travel restrictions and postponed events. However, our representatives and clinical teams are here for you and want to help you in whatever capacity you need.Finally, thank you for your efforts at this challenging time -You are all heroes to us!The LiDCO Team

http://www.lidco.com/wp-content/uploads/2020/03/COVID-19.pdf

Gringo, that is only £10k worth. Effectively 1 or 2 buys and it is clear, however after that we go back to paying a premium to get similar amounts.

TDT, I disagree. I know there are many posters on here skiving for a lower entry but I think you are all now clutching at straws.

Firstly, Mineralx rightly points out that Gold mining is considered an essential service.

Secondly, as pointed out by Stocksbof in the recent RNS Mr. Clemmey will continue in his position until 30 June 2020 to manage the upcoming drill programme on the Company's exciting Pyramid Gold Project in Nevada, USA and to ensure an orderly transition of responsibilities.

Anyone holding any other Covid19 shares?

Pre-Close Trading Update

LiDCO (AIM: LID), the hemodynamic monitoring company, provides the following pre-close update in respect of its performance for the full year ended 31 January 2020 ("FY20").



LiDCO continues to make progress with developing a strong recurring revenue base through its Software as a Service ("SaaS") High Usage Programme ("HUP") business model and has achieved an excellent second half performance.



LiDCO product revenues for FY20 were up 19% to £7.4m (FY19: £6.2m), in line with management expectations. The growth in LiDCO product revenues more than outweighed the expected reduction in low margin third-party product sales. As a result, total revenues (including third party products) were up by 3% to £7.6m (FY19: £7.3m). The increased proportion of higher margin LiDCO revenues led to an increase in overall gross margin.



The Company now has a global contracted base of 286 HUP monitors (FY19: 164), generating total annualised contracted licence revenues of £2.2m (FY19: £1.4m) an increase of 57%.



The 19% growth in FY20 LiDCO product sales reflects growth in all regions compared with the prior year. LiDCO product sales grew by 28% in the USA to £1.8m (FY19: £1.4m), by 1% in the UK to £3.6m (FY19: £3.6m) and sales outside of the Company's direct markets were up 60% to £2.0m (FY19: £1.3m). The significant growth outside the UK included £0.4m growth in China from the launch of the new monitor and, as a result sales outside the UK now represent just over half (FY19: 43%) of LiDCO product sales.



In the second half of the year there was a net cash inflow of £0.2m, compared with a net cash outflow in H1 of £0.5m. The balance sheet remains strong with cash balances at 31 January 2020 of £1.4m (2019: £1.7m) and the Company remains debt free.



The Board expects to report positive adjusted EBITDA1 for FY20 (FY19: -£1.2m).



Commenting, Matt Sassone, Chief Executive Officer of LiDCO, said: "After a strong first half in FY20, the team succeeded in delivering an even better second half performance. Our differentiated SaaS business model continues to drive our growth with the number of HUP monitors installed globally increasing nearly 75% and this has contributed to our expansion in recurring revenues. I am also pleased with our international sales growth as we now have the majority of our LiDCO product sales outside the UK, where we retain our market share and leadership position. This excellent performance leads to the expectation that we will report positive adjusted EBITDA for FY20."

https://www.reuters.com/article/brief-lidco-sells-more-monitors-to-hospi/brief-lidco-sells-more-monitors-to-hospitals-in-wuhan-due-to-covid-19-idUSFWN2B20B6

BRIEF-Lidco Sells More Monitors To Hospitals In Wuhan Due To Covid-19

1 Min Read

March 9 (Reuters) - Lidco Group PLC:

* LIDCO GROUP PLC - INCREASED CHINA SALES DEMAND DUE TO COVID-19

* LIDCO- BEIJING GLORYWAY MEDICAL RECENTLY SOLD SMALL NUMBER OF MONITORS IN WUHAN, CHINA AS A DIRECT RESPONSE TO COVID-19 VIRUS OUTBREAK

* LIDCO - IN TALKS WITH HEALTHCARE INSTITUTIONS IN NUMBER OF AFFECTED AREAS, PREPARED TO BE FLEXIBLE TO MEET ANY SHORTTERM INCREASED MONITORING NEEDS Source text for Eikon: